follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

ADMA Biologics Inc. closes $26.5M IPO

By

Back to Top Comments Print

Ramsey-based ADMA Biologics Inc. announced Tuesday the closing of its previously announced initial public offering of 3.35 million shares of its common stock at a public offering price of $8.50 per share.

According to the announcement, aggregate net proceeds to ADMA, after deducting underwriting discounts and commissions, will be approximately $26.5 million. Oppenheimer & Co. acted as sole book-running manager for the offering, first priced last week. Ladenburg Thalmann & Co. Inc., Maxim Group LLC and Laidlaw & Co. Ltd. acted as co-managers.

 

Write to the Editorial Department at editorial@njbiz.com

advertisement

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top